Skip to main content
Bio-Gate AG logo

Bio-Gate AG — Investor Relations & Filings

Ticker · BIG1 ISIN · DE000BGAG981 LEI · 391200G5LKTIOTZOXP90 F Manufacturing
Open in API
Filings indexed 242 across all filing types
Latest filing 2022-09-05 Earnings Release
Country DE Germany
Listing F BIG1

About Bio-Gate AG

https://www.bio-gate.de/en/

Bio-Gate AG is a provider of innovative technologies and customized solutions for health and hygiene, specializing in antimicrobial and antiviral strategies. The company enhances materials and products by incorporating its unique silver-based technologies, such as MicroSilver BG™. Key applications are concentrated in the medical technology sector, including the coating of medical implants and wound dressings to prevent infections. The company's technologies are also utilized in derma-cosmetics and veterinary care products. Furthermore, Bio-Gate provides solutions for industrial and consumer goods, imparting antimicrobial properties to items like paints, coatings, plastics, and textiles.

Recent filings

Filing Released Lang Actions
Bio-Gate AG: Bio-Gate bestatigt vorlaufige Halbjahreszahlen und angepassten Ausblick fur 2022
Earnings Release Classification · 100% confidence The document is titled "Bio-Gate bestätigt vorläufige Halbjahreszahlen und angepassten Ausblick für 2022" (Bio-Gate confirms preliminary half-year figures and adjusted outlook for 2022). It explicitly discusses financial results for the first half of the fiscal year ("Umsatz im Halbjahr von rund 2,6 Mio. Euro und Nettoergebnis von rund -1,1 Mio. Euro bestätigt") and provides an adjusted outlook for the full year 2022. This content structure—reporting on a specific, shorter reporting period (half-year) with key financial figures and management commentary—is characteristic of an Interim/Quarterly Report (IR). Although it confirms *preliminary* figures, the document itself contains the substance of the period's performance, making it more than just a simple announcement of a report (RPA/RNS). The mention of "Halbjahresbericht 2022" at the end confirms the context, but the document's primary function is presenting the interim results and outlook. H1 2022
2022-09-05 German
Bio-Gate erwartet trotz geopolitischer Unsicherheiten starke zweite Jahreshalfte 2022
Earnings Release Classification · 100% confidence The document text explicitly discusses the financial results for the first half of the fiscal year 2022 ("im ersten Halbjahr des Geschäftsjahres 2022"), provides preliminary, unaudited figures for revenue and earnings, and details an adjustment to the full-year forecast ("Umsatz- und Ergebnisprognosen wegen geopolitischer Auswirkungen angepasst"). This content structure—reporting on a period shorter than a year (six months) with financial details and outlook adjustments—is characteristic of an Interim/Quarterly Report (IR). It is more comprehensive than a simple Earnings Release (ER) which usually only contains highlights, and it is not the full Annual Report (10-K). The presence of the DGAP-News header and the reference to an Ad-hoc announcement further confirms this is a formal periodic financial disclosure. H1 2022
2022-08-18 German
Bio-Gate AG passt Umsatz- und Ergebnisprognose fur 2022 an
Earnings Release Classification · 100% confidence The document is an 'Ad-hoc' announcement dated August 17, 2022, explicitly stating it is an 'Insiderinformation nach Artikel 17 der Verordnung (EU) Nr. 596/2014' (Ad-hoc notification according to Art. 17 MAR). The core content involves the company, Bio-Gate AG, adjusting its revenue and earnings forecast for the fiscal year 2022 based on preliminary H1 2022 figures. This type of material, non-public information that significantly impacts the stock price and is released outside of standard periodic filings (like 10-K or IR), is best classified as a general Regulatory Filing (RNS) or potentially an Earnings Release (ER) if it were a standard quarterly update. However, since it is a specific, unscheduled revision of guidance mandated by market abuse regulation (MAR Article 17), and it doesn't fit the definition of a full Earnings Release (ER) which usually contains comprehensive period results, the most appropriate general category for mandatory, unscheduled regulatory disclosures that don't fit elsewhere is RNS. Given the content is a forecast change, it is a significant regulatory disclosure, but RNS serves as the best fit among the provided options for mandatory, non-periodic regulatory news. FY 2022
2022-08-17 German
Bio-Gate AG: Bio-Gate schliet einen weiteren Kooperationsvertrag mit weltweit tatigem Implantat-Hersteller
Regulatory Filings Classification · 100% confidence The document is a press release dated July 5, 2022, announcing a new cooperation agreement for coating orthopedic implants with a major medical device manufacturer. It details the business development, the technology involved (HyProtect), and the financial implications (licensing payments). The header uses 'DGAP-News' and the content is a news announcement about a contract ('Vertrag/Sonstiges'). This type of announcement, detailing a significant business development or contract without being a formal financial report (like 10-K or IR) or a management change (MANG), fits best under the general category for corporate news announcements that aren't strictly financial results or regulatory filings, but given the options, it is a specific corporate event announcement. Since it is not a formal financial report, earnings release, or management change, and it is a specific business update, it most closely aligns with a general corporate announcement. However, looking at the definitions, it is not a standard regulatory filing (RNS) unless it fails all others. It is a specific business update about a contract. Since there is no specific 'Contract Announcement' code, and it is not an Earnings Release (ER), Interim Report (IR), or Management Discussion (MDA), it is a general corporate news item. In the provided list, 'RNS' is the fallback for miscellaneous filings. However, the content is a detailed press release about a strategic contract win, which is often classified separately. Given the options, and recognizing this is a news release about a business event, it is not a standard financial filing. If we must choose from the list, and it's not a specific financial report, management change, or capital event, 'RNS' (Regulatory Filings/General Announcement) is the most appropriate fallback for a non-standard corporate news release, although 'LTR' (Legal Proceedings Report) or 'CAP' (Capital/Financing Update) are clearly incorrect. Since it is a news release about a contract, and not a formal regulatory filing like a 10-K or a specific financial report, 'RNS' serves as the best general corporate news category available.
2022-07-05 German
DGAP-DD: Bio-Gate AG deutsch
Director's Dealing Classification · 100% confidence The document text explicitly uses the header "Directors’ Dealings" and contains German text translating to "Notification and public disclosure of transactions by persons discharging managerial responsibilities, and persons closely associated with them" (Meldung und öffentliche Bekanntgabe der Geschäfte von Personen, die Führungsaufgaben wahrnehmen, sowie in enger Beziehung zu ihnen stehenden Personen). It details a transaction (acceptance of stock options) by an individual named Thomas Konradt, who holds the position of 'Vorstand' (Executive Board member). This directly corresponds to the definition of Director's Dealing.
2022-07-01 German
DGAP-DD: Bio-Gate AG deutsch
Director's Dealing Classification · 100% confidence The document is explicitly titled 'Directors’ Dealings' and contains detailed information regarding transactions by a person in a management position ('Vorstand' - Board Member) concerning company shares/options. Specifically, it details the acceptance of 27,000 stock options by Marc Lloret-Grau. This directly corresponds to the definition of Director's Dealing (insider trades) which is classified as 'DIRS'. The document structure and content are typical of mandatory insider transaction disclosures.
2022-07-01 German

Browse filings by year

21 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.